Image: NBC NewsFDA approves Lipfendra, a powerful cholesterol-lowering pill from Merck
β’ The FDA has approved Lipfendra, a new cholesterol-lowering pill developed by Merck. β’ Unlike traditional statins, Lipfendra is a PCSK9 inhibitor, utilizing a different mechanism to reduce cholesterol levels in patients. β’ This approval provides a new oral therapeutic option for managing high cholesterol, offering an alternative for those who may not respond well to statins.
nbcnews.com
